Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca in Mainland China
| TMIRX Fund | USD 10.38 0.17 1.67% |
Slightly above 55% of Transamerica Mid's investors are presently thinking to get in. The analysis of overall sentiment of trading Transamerica Mid Cap mutual fund suggests that some investors are interested at this time. Transamerica Mid's investing sentiment can be driven by a variety of factors including economic data, Transamerica Mid's earnings reports, geopolitical events, and overall market trends.
Transamerica |
Innovent Biologics, Inc. , a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major diseases, and Eli Lilly and Company today jointly announced a Distribution and Promotion Agreement in Mainland China regarding Lillys non-covalent Brutons tyrosine kinase inhibitor, Jaypirca pirtobru
Read at finance.yahoo.com
 |
Transamerica Mid Fundamental Analysis
We analyze Transamerica Mid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Transamerica Mid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Transamerica Mid based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Transamerica Mid is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Transamerica Mid Cap Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Transamerica Mid mutual fund to make a market-neutral strategy. Peer analysis of Transamerica Mid could also be used in its relative valuation, which is a method of valuing Transamerica Mid by comparing valuation metrics with similar companies.
Peers
Transamerica Mid Related Equities
Other Information on Investing in Transamerica Mutual Fund
Transamerica Mid financial ratios help investors to determine whether Transamerica Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transamerica with respect to the benefits of owning Transamerica Mid security.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |